PITTSBURGH--(BUSINESS WIRE)--RedPath Integrated Pathology, Inc., a molecular diagnostics company dedicated to the effective diagnosis and treatment of cancer, today announced that Mark D. Myslinski, RedPath’s president and chief executive officer, will share his perspectives on the rapidly expanding applications of molecular diagnostics at the 3 Rivers Venture Fair. The conference will be held in Pittsburgh, Pa., September 15-16, 2009.
